Skip to main content

Table 1 Characteristics of the participants according to presence of NAFLD

From: The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

 

Non-NAFLD

NAFLD

P value

Total, N (%)

6 412 (59.6%)

4 349 (40.4%)

—

Men, N (%)

3 622 (56.5%)

3 136 (72.1%)

<0.0001

Age, years

47.0 (36.0–57.0)

52.0 (43.0–59.0)

<0.0001

Body mass index, kg/m2

22.1 (20.4–23.8)

25.6 (24.0–27.4)

<0.0001

Systolic blood pressure, mmHg

120.0 (110.0–130.0)

128.0 (120.0–139.0)

<0.0001

Diastolic blood pressure, mmHg

75.0 (70.0–80.0)

80.0 (75.0–90.0)

<0.0001

Fasting plasma glucose, mmol/L

4.9 (4.6–5.3)

5.2 (4.8–5.8)

<0.0001

Triglycerides, mmol/L

0.9 (0.7–1.3)

1.6 (1.1–2.4)

<0.0001

Total cholesterol, mmol/L

4.4 (3.8–5.0)

4.8 (4.2–5.4)

<0.0001

HDL cholesterol, mmol/L

1.4 (1.2–1.6)

1.2 (1.1–1.4)

<0.0001

LDL cholesterol, mmol/L

2.6 (2.2–3.1)

3.0 (2.5–3.5)

<0.0001

Uric acid, μmol/L

282.0 (233.0–334.0)

333.0 (284.9–384.6)

<0.0001

White blood cell counts, ×109/L

5.5 (4.7–6.5)

6.1 (5.3–7.2)

<0.0001

Alanine aminotransferase, U/L

17.0 (13.0–24.0)

26.0 (18.0–37.0)

<0.0001

TyG

8.2 (7.8–8.6)

8.8 (8.4–9.3)

<0.0001

  1. Data are presented as median (interquartile range) or percentage
  2. TyG indicates the triglycerides and glucose index
  3. NAFLD: nonalcoholic fatty liver disease; HDL; high density lipoprotein; LDL; low density lipoprotein